CALL FOR PAPERS

CERTIFICATE

IMPACT FACTOR 2019

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

 

 

 

 

 

 

 

 

 

 

 

The -94 ins/delattg promoter polymorphism in the transcription factor nf-kb in patients with popliteal aneurysm

Author: 
Masoud Mirzaie, Sheila Fatehpur, Zaur Guliyev, Susanne Schulz and Stefan Reichert
Subject Area: 
Health Sciences
Abstract: 

Background: Popliteal aneurysms, with a frequency of 85% of all peripheral aneurysms, have a poor prognosis with a high amputation frequency. Up to now, the -94 ins/delATTG promoter polymorphism in the transcription factor NF‐κBhas been assumed to be involved in its pathophysiology. The aim of this study was to investigate the role of this genetic variant in patients with popliteal aneurysm. Patients and methods: In total, 48 patients with popliteal aneurysm (44 males, mean age 74.5 years) and 49 healthy controls (19 males, 51.5 years) were enrolled in the study. The duplex sonographic diagnosis of popliteal aneurysm was verified in each patient by CT angiography. Popliteal aneurysms were diagnosed when the diameter of the affected vessel was at least 15 mm. In subjects of the control group, duplex examination excluded the diagnosis of popliteal aneurysm. Smoking history, arterial hypertension, diabetes mellitus, hyperlipoproteinemia (HLP), hyperuricemia, coronary heart disease (CHD) and carcinoma were recorded as comorbidities. For the NF‐κB polymorphism, the -94 ins/del ATTG polymorphism (rs28362491) in the NF‐κBgene was investigated. Results: With 50.5%, the id genotype of -94 ins/del ATTG polymorphism was the most frequently encountered genotype (46.9% in the control group versus 54.2% in patients with popliteal aneurysm). At second position, the genotype ii followed with 35.1% (36.7% in the control group versus 33.3% in patients with popliteal aneurysm) and genotype dd with 14.4% (16.3% in the control group versus 12.5% in patients with a popliteal aneurysm). However, there was no significant difference in the distribution of genotypes. In the case of allele distribution, with 60.2% for allele i in the control group and 60.4% for allele i in patients with a popliteal aneurysm, and for allele d in 39.8% of the control group and 39.6% in patients with a popliteal aneurysm no significant differences could be found. Binary logistic regression analysis showed a clear association only between male gender and smoking with popliteal aneurysm but not for the -94 ins/del ATTG genotypes. Conclusion: In contrast to male gender and smoking habits, no significant differences in the genodistributions of -94 ins/del ATTG polymorphism were detected with respect to the diagnosis of popliteal aneurysms.

PDF file: 

IJMCE RECOMMENDATION

ONLINE PAYPAL PAYMENT

CURRENT ISSUE

NEWS

CHIEF EDITOR
Rosane Cavalcante Fragoso, Brasil
ASSOCIATE CHIEF EDITOR

   

Jean-Marc SABATIER
Chief Scientific Officer and Head of a Research Group
France

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

 

 

 

 

 

 

 

 

 

 

 

EDITORIAL BOARD

Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran